Phase II study of imatinib mesylate and docetaxel in patients with metastatic or recurrent head and neck squamous cell cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2012
At a glance
- Drugs Docetaxel; Imatinib
- Indications Head and neck cancer
- Focus Therapeutic Use
- 16 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 21 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center record.